The research team would immediately refer to the site’s policies on trial-related harms in order to refer attacked trial participants to partnered stakeholders who offer clinical, medical, psycho-social or legal support services as the case may be. If solutions to this sort of problem is not available in the trial-related harm policies, the team would work with the CAB, MSM advocacy groups, legal groups and other relevant stakeholders to discuss the best ways to handle the situation and also in corporate the solutions in the policies.

However, the team and stakeholders should have developed an effective communications plan that would create in depth understanding of the trial research among community members and the public at large.